T1	Participants 129 169	patients with non-small-cell lung cancer
T2	Participants 351 400	patients with non-small-cell lung cancer (NSCLC),
T3	Participants 1291 1303	147 patients
T4	Participants 1321 1384	median age: 60Â±8 years, PS 0/1/2: 44/83/20 patients; males: 78%